Other reports of cerivastatin-induced rhabdomyolysis

被引：2

作者：

Gabay, M

Lodolce, A

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 2001年 / 161卷 / 21期

关键词：

D O I：

10.1001/archinte.161.21.2629

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：2629 / 2629

页数：1

相关论文

共 9 条

[1] Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil
Alexandridis, G
Pappas, GA
Elisaf, MS
[J]. AMERICAN JOURNAL OF MEDICINE, 2000, 109 (03) : 261 - 262
[2] Rhabdomyolysis in a patient receiving the combination of cerivastatin and gemfibrozil
Bermingham, RP
Whitsitt, TB
Smart, ML
Nowak, DP
Scalley, RD
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (05) : 461 - 464
[3] Acute rhabdomyolysis associated with cerivastatin therapy
Garcia-Valdecasas-Campelo, E
Gonzalez-Reimers, E
Lopez-Lirola, A
Rodriguez-Rodriguez, E
Santolaria-Fernandez, F
[J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (06) : 893 - 893
[4] Özdemir Ö, 2000, ANGIOLOGY, V51, P695
[5] Influenza vaccine - a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate
Plotkin, E
Bernheim, J
Ben-Chetrit, S
Mor, A
Korzets, Z
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (05) : 740 - 741
[6] Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy
Pogson, GW
Kindred, LH
Carper, BG
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (07) : 1146 - +
[7] Cerivastatin-induced rhabdomyolysis
Rodríguez, ML
Mora, C
Navarro, JF
[J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (07) : 598 - 598
[8] Extending therapy options in treating lipid disorders - A clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor
Stein, EA
[J]. DRUGS, 1998, 56 (Suppl 1) : 25 - 31
[9] HMG-CoA reductase inhibitors and myotoxicity
Ucar, M
Mjörndal, T
Dahlqvist, R
[J]. DRUG SAFETY, 2000, 22 (06) : 441 - 457